NCT00549211

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

A Two-Part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of GSK557296 in a Randomized, Single-Blind, Placebo-Controlled, Dose-Rising Design, and to Evaluate the Effect of Food on Single Oral Doses of GSK557296 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (estimated)
• Sponsor: GlaxoSmithKline · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.

Conditions

• Obstetric Labour, Premature
• Premature Ejaculation

Interventions

Type	Name	Description
DRUG	GSK557296

Timeline

• Start date: 2007-10-01
• First posted: 2007-10-25
• Last updated: 2012-03-19

Locations

1 site across 1 country: United States